Antibiotic Developments
Accelerate Diagnostics announces CE marking of its antimicrobial kit
Accelerate Diagnostics, an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, announces CE marking of its new Accelerate Arc Module and BC kit. Read more
8 Aug 2022
Quidel Corp provides rapid clinical detection of C. difficile infection
The Sofia 2 C. difficile FIA (Fluorescent Immunoassay), from healthcare manufacturer Quidel Corporation, provides accurate detection of C. difficile in 15 minutes – half the time of comparator assays – allowing rapid treatment decisions. Read more
1 Jul 2022
Novasep and Paratek increase API manufacture for antibiotic
Technology supplier Novasep and Paratek Pharmaceuticals have signed an agreement to increase the commercial production of an active pharmaceutical ingredient (API) for an antibiotic. Read more
21 Feb 2022
Antimicrobial resistance a leading cause of global deaths, study shows
Antimicrobial resistance (AMR) has been found to be a leading cause of death worldwide in a study published in The Lancet. Read more
20 Jan 2022
BioVersys receives funding to develop new class of antibiotics to treat multidrug-resistant bacterial infections
Switzerland-based pharmaceutical company BioVersys has been awarded up to $4.35 million in funding to develop a new class of antibiotics for its work in developing a new class of antibiotics. Read more
7 Jun 2021
Current pipeline for antibiotics insufficient in tackling drug resistance
The current pipeline for antibiotics is insufficient in addressing drug resistance in the world’s most dangerous bacteria, a new report by the World Health Organisation has revealed. Read more
21 Apr 2021
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can help combat this to make diagnosing AR a quicker process. Read more
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
Sponsored Content
Disease-modifying heart failure drug in development
Sequana Medical NV, announces the completion of enrolment in its Phase 2a SAHARA proof-of-concept study using its first-generation DSR product (DSR 1.0) as treatment for congestive heart failure. Read more
15 Aug 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
UoB launches method to increase efficiency of biocatalysis
Birmingham scientists have revealed a new method to promote biofilm formation and increase efficiency in biocatalysis, in a paper published today in Materials Horizons. Read more
15 Aug 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Roquette expands mannitol range for highly sensitive APIs
Roquette, a provider of plant-based ingredients and pharmaceutical excipients, announces the addition of a new grade to its PEARLITOL SD mannitol range for direct compression – PEARLITOL 150 SD. Read more
12 Aug 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
DuPont to commercialise pharma silicone tubing produced in China
DuPont will increase production capabilities for its Liveo Pharma Silicone Tubing by adding manufacturing capacity in eastern China. The expansion aims to meet demand for high-quality, high-performance biopharmaceutical tubing in Greater China. Read more
12 Aug 2022
SGS Quay Pharma receives Queen's Award for industry
Pharmaceutical CDMO, SGS Quay Pharma, has received its Queen’s Award for Enterprise. The award was presented by the Lord Lieutenant of Clwyd, Henry Fetherstonhaugh, OBE, in a ceremony at the company’s global headquarters in Deeside Industrial Park. Read more
12 Aug 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Bio-Rad extends range of anti-idiotypic antibodies for bioanalysis
Bio-Rad Labs extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to brentuximab vedotin (Adcetris), secukinumab (Cosentyx), and the secukinumab–interleukin 17A drug-target complex. Read more
12 Aug 2022
Sponsored Content
Lonza - New Webinar: Solid Form Screening and Rapid Formulation Selection to Meet Demands of Accelerated Timelines
Compare formulation strategy advantages and disadvantages through case studies Read more
1 Jun 2022
White Papers
Sponsored Content
Sponsored Content
Lonza - New Webinar: Solid Form Screening and Rapid Formulation Selection to Meet Demands of Accelerated Timelines
Compare formulation strategy advantages and disadvantages through case studies Read more
1 Jun 2022
Precision Polymer Engineering
A leading international manufacturer of high performance elastomer seals and components for a range of critical applications and Read more